Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma

NCT07369492 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Lymphoma

Interventions

BIOLOGICAL: BAFF-R CAR-T cells

Sponsor

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.